BAUSCH AND LOMB FDA Approval NDA 020065

NDA 020065

BAUSCH AND LOMB

FDA Drug Application

Application #020065

Documents

Letter2005-04-28
Letter2007-08-02
Label2007-08-02
Letter2022-09-26
Label2022-10-05

Application Sponsors

NDA 020065BAUSCH AND LOMB

Marketing Status

Over-the-counter001

Application Products

001SOLUTION/DROPS;OPHTHALMIC0.02675%;0.315%1OPCON-ANAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE

FDA Submissions

TYPE 5; Type 5 - New Formulation or New ManufacturerORIG1AP1994-06-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1994-11-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1994-11-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1995-05-11STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1996-04-11STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1996-03-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2005-04-20STANDARD
LABELING; LabelingSUPPL11AP1996-05-09STANDARD
LABELING; LabelingSUPPL13AP1996-07-23STANDARD
LABELING; LabelingSUPPL14AP1996-07-23STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1996-12-18STANDARD
LABELING; LabelingSUPPL17AP2007-07-31STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL20AP2015-05-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL21AP2015-09-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL22AP2016-03-14STANDARD
LABELING; LabelingSUPPL33AP2022-09-23STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL5Null0
SUPPL8Null0
SUPPL9Null0
SUPPL10Null0
SUPPL15Null0
SUPPL20Null0
SUPPL21Null0
SUPPL22Null0
SUPPL33Null31

CDER Filings

BAUSCH AND LOMB
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20065
            [companyName] => BAUSCH AND LOMB
            [docInserts] => ["",""]
            [products] => [{"drugName":"OPCON-A","activeIngredients":"NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE","strength":"0.02675%;0.315%","dosageForm":"SOLUTION\/DROPS;OPHTHALMIC","marketingStatus":"Over-the-counter","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"07\/31\/2007","submission":"SUPPL-17","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/020065s017lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"OPCON-A","submission":"NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE","actionType":"0.02675%;0.315%","submissionClassification":"SOLUTION\/DROPS;OPHTHALMIC","reviewPriority":"Over-the-counter","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2007-07-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.